Results 271 to 280 of about 273,161 (350)

Clonal hematopoiesis of indeterminate potential (CHIP) and risk of non-Hodgkin lymphoma: A community-based cohort study. [PDF]

Hemasphere
Liu M, Zhou L, Liu Q, Wang X, Wei H, Liu Q.   +5 more
europepmc   +1 more source

Over one‐third of cancer cases and two‐fifths of cancer deaths in southern China are preventable: Insights from the latest representative population‐based cancer registry data and risk factor survey

International Journal of Cancer, Volume 158, Issue 4, Page 909-923, 15 February 2026.
What's new? This study quantified the cancer burden attributable to modifiable risk factors in Guangdong, the most populous and economically advanced province in southern China. By evaluating 15 modifiable risk factors, the study reveals that over one‐third of cancer cases and two‐fifths of cancer deaths in the region could potentially be prevented ...
Xiaolan Wen, Yu Liao, Jiayue Li, Qian Zhu, Xinmei Lin, Bingfeng Han, Li Li, Ru Chen, Ruilin Meng, Ni Xiao, Xueyan Zheng, Xiaojun Xu, Dejian Zhao, Yue Gao, Liming Pu, Ye Wang, Wenqiang Wei, Shaoming Wang   +17 more
wiley   +1 more source

Global burden and trends of childhood non-Hodgkin lymphoma from 1990 to 2021. [PDF]

Front Pediatr
Xie J, Xu JS, Huang JW, Zheng YS.
europepmc   +1 more source

Safety and Efficacy of Anticoagulation Therapy in Paediatric Patients With Solid Tumours or Lymphomas at Risk of Thrombocytopenia: A Retrospective Study

Pediatric Blood &Cancer, Volume 73, Issue 2, February 2026.
ABSTRACT Background Patients with solid tumours or lymphomas have an increased risk of thromboembolism (TE) and thrombocytopenia. Evidence‐based strategies for anticoagulation therapy (ACT) for patients with thrombocytopenia are limited. We examined the impact of thrombocytopenia on ACT administration and bleeding incidence in children with solid ...
Andrés Felipe Fajardo, Katherine Talpin, Bishal Harry, Uma H. Athale, Anthony K. C. Chan, Mihir D. Bhatt   +5 more
wiley   +1 more source

Correlates and Detection of Digital Health Literacy in Patients With Colorectal Carcinoma or Non-Hodgkin Lymphoma: Cross-Sectional Study.

JMIR Cancer
Gunning TS, Khoudary A, Billini O, Ip A, Sorgen L, Marshall J, Weinberg BA, Potosky AL, Schwartz MD, Conley CC, Derry-Vick HM.   +10 more
europepmc   +1 more source

Persistent Respiratory Symptoms Post-COVID-19 in a Non-Hodgkin Lymphoma Patient: A Case Report. [PDF]

Cureus
Dimeas IE, Papra S, Dimeas G, Pantazopoulos I, Daniil Z.   +4 more
europepmc   +1 more source

What to Do When Medical Evidence Can Only Be Generated Through Routine Data: An Example From Pediatric Oncology

Pediatric Blood &Cancer, Volume 73, Issue 2, February 2026.
ABSTRACT Children undergoing allogeneic stem cell transplantation often receive off‐label rituximab treatment for Epstein–Barr virus reactivation, using adult dosing without pediatric evidence. This project aims to develop a clinical decision support tool (CDSS) that provides evidence‐based dosing scenarios by analyzing real‐world patient data.
Birgit Burkhardt, Antje Walz, Dietrich Knoerzer   +2 more
wiley   +1 more source

Levofloxacin for the prevention of febrile episodes in non-Hodgkin lymphoma patients treated with CHOP plus rituximab in a randomized controlled trial. [PDF]

Sci Rep
Surakijboworn M, Polprasert C, Wudhikarn K, Rojnuckarin P, Uaprasert N.   +4 more
europepmc   +1 more source

Prognostic implication of serum levels of IL-6 and IL-10 in children and adolescents with aggressive mature B-cell non-Hodgkin lymphoma. [PDF]

BMC Cancer
Zeng C, Wei Z, Huang J, Zhu J, Sun F, Wang J, Lu S, Zhang Y, Sun X, Zhen Z.   +9 more
europepmc   +1 more source

Blood virome profiling reveals subtype-specific viral signatures and reduced diversity in non-Hodgkin lymphoma. [PDF]

Virulence
Pan S, Li W, Zhao X, Wang H, Liu J, Zhang W, Zhou C, Xie Y.   +7 more
europepmc   +1 more source